Triolab Group has operated in the Nordics for over 30 years. Our extensive experience and understanding of the local diagnostics and life science market enable an active development of the product range and make it possible for us to offer suppliers a specialist distribution and support organisation.
- we know how the local healthcare systems are organised and financed
- we have close contacts in local research and healthcare organisations
- we work with the local key opinion leaders
- we speak the local languages
We operate in all the Nordic countries: Denmark, Finland, Iceland, Norway and Sweden.
Nordic Country Facts
|Denmark||5,7 M||289 000 M€||29 000 M€||153 M€||0,5 %|
|Finland||5,5 M||224 000 M€||21 000 M€||110 M€||0,5 %|
|Iceland||0,3 M||22 000 M€||2 000 M€||11 M€||0,6 %|
|Norway||5,3 M||354 000 M€||36 000 M€||180 M€||0,5 %|
|Sweden||10,0 M||475 000 M€||50 000 M€||184 M€||0,4 %|
Source: MedTech Europe – European IVD Market Statistics Report 2017
GDP = gross domestic product
THE = total healthcare expenditure
IVD = in vitro diagnostics market